Background-New vessel formation contributes to organ development during embryogenesis and tissue repair in response to mechanical damage, inflammation, and ischemia in adult organisms. Early angiogenesis includes formation of an excessive primitive network that needs to be reorganized into a secondary vascular network with higher hierarchical structure. Vascular pruning, the removal of aberrant neovessels by apoptosis, is a vital step in this process. Although multiple molecular pathways for early angiogenesis have been identified, little is known about the genetic regulators of secondary network development. Methods and Results-Using a transcriptomics approach, we identified a new endothelial specific gene named FYVE, RhoGEF, and PH domain-containing 5 (FGD5) that plays a crucial role in vascular pruning. Loss-and gain-of-function studies demonstrate that FGD5 inhibits neovascularization, indicated by in vitro tube-formation, aortic-ring, and coated-bead assays and by in vivo coated-bead plug assays and studies in the murine retina model. FGD5 promotes apoptosis-induced vaso-obliteration via induction of the hey1-p53 pathway by direct binding and activation of cdc42. Indeed, FGD5 correlates with apoptosis in endothelial cells during vascular remodeling and was linked to rising p21 CIP1 levels in aging mice.
V ascularization during development and regeneration plays a vital role in adult disease progression, including tumor growth and metastasis, arthritis, diabetic retinopathy, and cardiovascular disease. Vascular growth in both development and disease consists of a strictly orchestrated, multistep process that requires integrated activation of several molecular pathways. During early vascular growth, a dense primary vascular network without functional arterial and venous distinction is formed in response to low-oxygen conditions. This primitive system, consisting of small capillaries, is relatively unstable, with tip and stalk cell vessel structures expanding and collapsing at a high rate. Transition of this primary network into a stable secondary vasculature with a defined arterial/venous hierarchy of larger vessels that branch into a restricted capillary field requires intensive vascular remodeling, a late angiogenic process that includes neovessel stabilization and pruning of redundant vessel structures. 1, 2 
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The molecular regulation by angiogenic factors such as vascular endothelial growth factor (VEGF)-A and fibroblast growth factor that promote growth of the primary vasculature has been studied extensively. In contrast, the key molecular pathways that regulate the reorganization of this early network into the more mature secondary vascular structure are still largely undefined. For the process of vascular pruning, vaso-obliteration by apoptosis induced by hyperoxia has been described, 3 but little is known about the molecular regulation of this important aspect in vascular remodeling that determines the fate of the neovasculature. Here, we define the function of an endothelial cell (EC)-specific gene that plays a crucial role in apoptosis during vascular pruning.
Previously, we conducted a genome-wide expression profile analysis to identify potential trivial regulators in angiogenesis. A new gene named FYVE, RhoGEF, and PH domain-containing 5 (FGD5) was discovered that showed specific expression in endothelial precursor cells in developing murine embryos and vasculature of zebrafish larvae and mature mice. The FGD family members of Rho guanine-nucleotide exchange factors (GEFs) include FGD1 through FDG6, as well as the FGD1-related cdc42-GEF, 4 -8 all sharing the Dbl homology, FYVE, and pleckstrin homology (PH) domains. FGD1, FGD4, and FRG have been shown to control cdc42 activity via their Dbl homology domain by converting inactive GDP-bound cdc42 into active GTP-bound cdc42, resulting in altered capacities in actin cytoskeleton assembly, filopodia formation, and Jun N-terminal kinase pathway activation. 9 -13 To date, the basic function of FGD5 remains unknown.
Our studies, which incorporate gain and loss of function of the FGD5 gene, demonstrated in vitro and in vivo that FGD5 induces vascular regression by pruning of redundant neovessels during neovascularization. FGD5 functions as a RhoGEF that binds and activates its direct target, cdc42, and therefore promotes Hey1-dependent p53-mediated apoptosis in ECs. The GFD5 mRNA level also correlates with rising p21 CIP1 levels in aging C57/bl6 wild-type mice, which coincides with a decline in CD31 expression. These findings identify FGD5 as a novel, critical regulator of neovasculature fate during late-phase angiogenesis and demonstrate that FGD5 may act as a defining factor for vascular regression in later adult life.
Methods

Isolation of Flk ؉ and Flk ؊ Cells From Mouse Embryos
First, 10.5 to 15.5 days post coital FVB/N mouse embryos were harvested and digested to obtain single-cell suspensions in 0.12% collagenase type I/PBS in 10% FCS (Sigma C-0130; Sigma, Zwijndrecht, the Netherlands). Single-cell suspensions were labeled with 1:50 Flk1 phycoerythrin mouse antibody and 1:100 Hoechst (BD Bioscience, Temse, Belgium) and sorted to Ͼ95% purity for Flk ϩ / Hoechst cells with a Diva fluorescence-activated cell sorter (FACS). Cells were dissolved in RLT (RNA isolation) buffer and processed for quantitative polymerase chain reaction (qPCR) analysis.
qPCR and Western Blot Analysis
RNA was isolated with the RNAeasy kit (Qiagen, Venlo, the Netherlands), checked for quality and quantity by capillary electrophoresis (Agilent 2100 Bioanalyzer; Agilent Technologies, Venlo, the Netherlands), and reversed transcribed into cDNA. qPCR reactions were performed by real-time fluorescence assessment of the SYBR Green signal with the iCycler iQ Detection System (Bio-Rad, Veenendaal, the Netherlands). qPCR analysis was performed for transcripts of mouse FRG, FGD1 through FGD6, endothelial nitric oxide synthase, p21 CIP1 , and CD31, as well as for human VEGF receptor (VEGFR) 1/2, Notch1/4, DLL4, jagged1, ephrin B2/B4, NRP1/2, p53, and Hey1. Target mRNA expression levels are reported relative to the housekeeping genes, hypoxanthine guanine phosphoribosyl transferase (Hprt1) in murine samples and ␤-actin in the human samples, as previously described 14 (All primer sequences  are provided in Tables I and II in the online-only Data Supplement) . For Western blot analysis, samples were lysed in NP40 buffer and analyzed on a 1.5% SDS-PAGE gel, followed by Western blotting with 1:1000 rat anti-p21 CIP1 and anti-p53 antibody (Abcam, Cambridge, UK); 1:500 rabbit anti-cdc42, anti-Rac1, and anti-RhoA antibody (Abcam, Cambridge, UK); and 1:500 mouse anti-FGD5 antibody (Bioscience, Temse, Belgium) for protein detection. Protein bands were visualized with the Li-Cor detection system (Westburg, Leusden, the Netherlands) as previously described. [15] [16] [17] 
Histological Analysis
Mouse ventricle, aorta, and carotid arteries were embedded in optical cutting temperature (Sakura Finetek, Hoge Rijndijk, the Netherlands) and snap-frozen in liquid nitrogen. Then, 5-m cryosections were double stained with Alexa Fluor-coupled isolectin IB4 (1:500; Invitrogen) and 1:100 mouse anti-FGD5 (Bioscience, Temse, Belgium), followed by FITC/rhodamin-labeled anti-mouse IgG antibody detection (1:500; Invitrogen, Breda, the Netherlands) and goat FAB against mouse IgG (HϩL) for blocking (Jackson Immunoresearch Laboratories, Sacramento, CA) as previously described. 18, 19 
Primary Cell Culture Conditions
Primary human umbilical vein ECs (HUVECs; Lonza, Breda, the Netherlands) were cultured on gelatin-coated plates at 37°C/5% CO 2 in EGM2 medium (EBM2 medium supplemented with commercial bullet kit and 2% FCS) with penicillin/streptomycin (Lonza, Breda, the Netherlands). Only cell cultures of passages 3 through 5 were used throughout the experiments. For immunohistological staining, HUVECs were grown on coverslips and fixed in ice-cold acetone for 5 minutes, followed by permeabilization in 0.1% Triton X/PBS, incubation with 1:100 mouse anti-FGD5 (Bioscience), and subsequent trichostatin A amplification of the signal (Roche, Woerden, the Netherlands). This was followed by incubation with 1:500 rabbit anti-cdc42 (Abcam, Cambridge, UK) or rat anti-zyxin (1:500; Abcam, Cambridge, UK) and detection with 1:500 FITC-labeled anti-rabbit/rat IgG antibody (Invitrogen, Breda, the Netherlands). Coverslips were mounted with Vectashield/DAPI (Brunschwig, Amsterdam, the Netherlands) and imaged by fluorescence microscopy (Carl Zeiss Inc, Sliedrecht, the Netherlands).
Mouse Retinal Angiogenesis Model
Three-day-old C57bl/6 pups were anesthetized by placement on ice. Then, 0.5 L adenovirus (Ad)-FGD5 (5ϫ10 7 plaque-forming units [pfu]) was injected intravitreally into the left eye and 0.5 L sham adenovirus (5ϫ10 7 pfu) was injected into the right eye with a 33-gauge needle. For FGD5 silencing experiments, 100 nmol Accell siRNA targeting murine FGD5 was intravitreally injected into the left eye and 100 nmol Accell scrambled nontargeting siRNA was injected into the right eye (Dharmacon, Ettenleur, the Netherlands). For rescue experiments with VEGFR1, an active soluble form of VEGFR1 was coinjected with 100 nmol Accell siFGD5. Depending on the assay, pups were euthanized at post natal day 4, 6, 8, 11, 16, and 21, and retinas were stained with rhodamin/FITC isolectin IB4 (1:200) or rabbit anti-collagen IV antibody (1:200; Millipore, Amsterdam, the Netherlands), followed by Alexa Fluor-labeled anti-rabbit/mouse secondary antibodies (1:500; Invitrogen). Wholemount retinas were visualized by confocal microscopy (LSM510 NLO/FCS; Zeiss, Sliedrecht, the Netherlands) using a ϫ10 lens to obtain high-resolution micrographs of the topical vascular layer. Postprocessing was needed to reassemble the individual micrographs into an overview of the entire retina. Processed retina images were analyzed with a commercial analysis system (Angiosys, Buckingham, UK). At least 3 individual retinal flaps per mouse retina were assessed.
Adequate transgene expression and gene silencing were validated by qPCR analysis. For flow cytometric assessment of the retinal ECs, the retina was homogenized in 0.12% collagenase type I (Sigma C-0130, Zwijndrecht, the Netherlands) in PBS/10% FCS for 15 minutes, filtered through a 3-m mesh (BD Biosciences, Temse, Belgium), and stained with 1:50 phycoerythrin-labeled mouse anti-Flk1 antibody, followed by annexin V and propidium iodide (PI) staining (BD Biosciences, Temse, Belgium). The percentage of apoptotic cells in the Flk1 ϩ population was quantified by flow cytometry (FACScanto; BD Biosciences, Temse, Belgium). For detection of cleaved caspase 3 and FGD5, retinal cells were fixed and permeabilized with the Cytofix/Cytoperm system (BD Biosciences, Temse, Belgium), followed by rabbit anti-FGD5 (Sigma, Zwijndrecht, the Netherlands) and secondary antibody staining with an allophycocyanin-labeled mouse anti-rabbit antibody, followed by FITC-labeled rabbit anti-cleaved caspase 3 and phycoerythrinlabeled mouse anti-Flk1 antibody staining and subsequent quantification by flow cytometry.
In Vivo Coated-Bead Assay
Mature severe combined immunodeficiency (SCID) mice (age, 10 -15 weeks) were injected subcutaneously with 700 beads in 300 L Matrigel (400 HUVECs per bead; BD Biosciences, Temse, Belgium) supplemented with 2.5 ng/mL rat fibrinogen and 20 ng/mL human basic fibroblast growth factor. For each animal, a sham virusand an FGD5-expressing HUVEC-coated bead plug was implanted in each flank. At day 8, solidified Matrigel plugs were retrieved, washed, fixed in 4% PFA/PBS, and imbedded in optimal cutting temperature (Sakura Finetek, Hoge Rijndijk). For validation of transgene expression, qPCR analyses were conducted on isolated plugs obtained at different time points. Then, 5-m cryosections were stained by hematoxylin and eosin staining or by rat anti-human CD31 (1:500) and rhodamin-labeled anti-rat IgG secondary antibody (1:500; R&D Systems, Breda, the Netherlands). For quantification of the percent nuclei and percent CD31 ϩ cells, data analysis was performed with a commercial image analysis system (Impak C; Clemex Technologies, Quebec, Canada).
Cell Proliferation, Apoptosis, and Cell Cycle Analysis
Transfected HUVECs were synchronized in the G 0 /G 1 phase by serum deprivation in EGM2/0.2% FCS for 12 hours. For cell growth assessment, cells were harvested and quantified with a hematocytometer (trypan blue negative) at different time points. We performed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide uptake experiments for cell metabolism assessment according to the manufacturer's protocol (ATCC). For cell cycle analysis, cells were harvested at 0, 4, and 12 hours after activation; fixed in 70% ethanol/PBS for 15 minutes on ice; stained with PI (1:300); and analyzed by flow cytometry. For apoptosis analysis, cells were harvested at 0, 4, and 12 hours after activation and stained for annexin V and PI signals with an annexin V apoptosis detection kit (BD Biosciences, Temse, Belgium), followed by analysis of the samples by flow cytometry (FACScanto, BD Bioscience, Temse, Belgium).
Small G Protein Activation Assay and FGD5-Protein Complex Coimmunoprecipitation
GTP-RhoA, Rac1, and cdc42 activation levels were measured with the G-lisa detection system (Tebu-Bio, Heerhugowaard, the Netherlands). For FGD5-protein complex coimmunoprecipitation, magnetic beads (Dynabeads, Invitrogen, Breda, the Netherlands) were coated and cross-linked with 2.5 g anti-FGD5 antibody (Bioscience) before immunoprecipitation overnight at 4°C with protein cell lysates of transfected HUVECs (50 g total protein in 100 L incubation buffer supplied by the G-lisa system). Beads were washed and protein samples were eluted with elution buffer (Invitrogen) before analysis by Western blot on a 12.5% SDS-PAGE gel.
Statistical Analysis
Results are expressed as meanϮSEM, and statistical analysis was performed by 1-way ANOVA and Student t test. In specific assays, repeated measurement analysis was applied. A value of PϽ0.05 was considered significant.
Additional descriptions of the materials and methods used in this study are provided in the online-only Data Supplement.
Results
FGD5 Is Specifically Expressed in Endothelial Precursor Cells During Murine and Zebrafish Development and in Fully Differentiated ECs
FGD5 was specifically expressed in the Flk1 ϩ cell population during embryonic development in mice as shown by microarray and qPCR. FGD5 mRNA was predominantly expressed in 8.5 days post coital until 16.5 days post coital Flk1 ϩ endothelial precursor cells, when the majority of the vascular structures were established ( Figure 1A ). Selection of endothelial precursor cells based on the Flk1 cell surface marker was further validated by microarray analysis, which showed a significant rise in the expression levels of well-known angiogenic genes such as angiopoietin 2, neuropilin 1 and 2, Tie1, Flt1, and Ets1 in the Flk1 ϩ compared with the Flk1 Ϫ pool (data not shown).
Specific vascular expression of FGD5 in the developing vascular tree was validated in zebrafish larvae by wholemount in situ hybridization ( Figure 1B ). FGD5 mRNA in mature C57/bl6 mice was expressed predominantly in the aorta and carotid arteries compared with heart, skeletal muscle, kidney, liver, eye, and brain tissue ( Figure 1C ), mimicking the expression profile of endothelium-specific markers, including endothelial nitric oxide synthase and CD31. The other FGD family members showed a ubiquitous expression pattern ( Figure 1D ). In vitro, FGD5 was specifically expressed in primary human arterial ECs and HUVECs compared with nonrelevant cells (Hela and sarcoma cells; Figure 1E ), underlining endothelium-specific expression throughout different species and developmental stages. Immunohistological analysis demonstrated selective FGD5 expression in ECs in the microvasculature of the myocardium and in the endothelial lining of large blood vessels, including the aorta ( Figure 1F and 1G). These findings were further confirmed by analysis of public gene expression databases (NCBI, Gene Expression Omnibus; Figure I in the onlineonly Data Supplement). From these results, we conclude that FGD5 is the predominant member of the FGD family expressed in ECs during embryonic vascular development and in adult vasculature. To assess the role of FGD5 in angiogenesis in vivo, beads coated with Ad-FGD5 or sham adenovirus-transfected HU-VECs were suspended in Matrigel and injected subcutaneously in immunodeficient SCID mice. Matrigel FGD5 plugs harvested at day 8 after transplantation revealed reduced plug vascularization, whereas the sham plugs showed an extensive neocapillary network (Figure 2A-2D ) and increased outgrowth of CD31 ϩ cells (Figure 2E and 2F). Human FGD5 transgene expression in the plugs was validated at different time points by qPCR analysis and showed significantly higher levels of human FGD5 mRNA in plugs with Ad-FGD5-versus sham virus-treated HUVECs ( Figure 2G ). FGD5 function in angiogenesis was further assessed with an Figure 3A-3C ). Adenoviral murine FGD5 overexpression after intravitreal injection at p3 (0.5ϫ10 7 pfu) reduced the vascular retinal network in the developing murine eye mainly at p8 and p11 ( Figure 3A) and is characterized by truncations in the superficial vasculature resulting in a decrease in total vascular tube length, number of junctions, and neocapillaries, whereas mean tube length was increased at the earliest time point ( Figure 3B and 3C) . SiRNA-mediated FGD5 knockdown substantiates these findings, because FGD5 knockdown at p3 resulted visa versa in an extended retinal vascular bed with persistence of excessive branches and tube structures that failed to be removed during the vascular remodeling process ( Figure 3D-3F ). qPCR analysis validated that murine FGD5 mRNA expression in the Ad-FGD5-treated retinas was significantly increased compared with treatment with sham virus until p6. Similarly, FGD5 targeting siRNA-treated retinas showed a significant reduction in levels of endogenous FGD5 at similar time points (p4 and p6) compared with transfection with nontargeting scrambled siRNA-treated retinas ( Figure  3G ). High-resolution representative retina examples of the FGD5 gain and loss of function are provided in Figure IIW in the online-only Data Supplement. Alteration in FGD5 expression levels during retinal vascularization did not affect the expansion rate of the vascular bed, as evidenced by the fact that the front of the networks reached the border zones of the retina in all of the assessed conditions by p8 ( Figure 3A and 3D). This points toward a role in active pruning of preestablished neovessels rather than an inhibitory function in neovessel formation for FGD5. To evaluate this further, Ad-FGD5treated retinas were assessed for neovessel retraction as visualized by whole-mount collagen IV/isolectin IB4 staining. The number of exposed collagen IV basement membrane sheets at p8 was significantly increased in FGD5overexpressed conditions compared with sham virus-treated controls ( Figure 3H ). Further evidence was provided by FACS analysis, demonstrating that FGD5 overexpression in the retinal bed decreased the percentage of Flk1 ϩ or CD31 ϩ (endothelial) cells ( Figure 4A and 4B) at p6 as a result of increased apoptosis, as revealed by PI/annexin V analysis ( Figure 4C and 4D) . Combined, these data indicate that FGD5 plays a significant role in the regression of the retinal vascular network.
FGD5 Diminishes Angiogenesis In Vitro and In Vivo
FGD5 Induces Apoptosis in ECs via an Hey1-p53 Regulatory Pathway
The observed antiangiogenic effects of FGD5 may be attributed to changes in EC proliferation and survival. FGD5expressing HUVECs showed a reduced growth rate compared with sham virus-transfected controls ( Figure IIIA Hey1 was previously associated with p53-mediated apoptosis, 21 suggesting that Hey1 could mediate FGD5-induced apoptosis in ECs. Here, we assessed the function of Hey1 in FGD5-mediated apoptosis. Hey1 knockdown in FGD5expressing HUVECs could rescue growth inhibition induced by FGD5 ( Figure 5A ). It also diminished p53 and p21 CIP1 protein levels ( Figure 5B and 5C) and reversed ECs from FGD5-induced apoptosis ( Figure 5D and 5E). PI-aided cell cycle analysis suggested that FGD5 enhanced the sub-G 1 apoptotic fraction, whereas the percent of alive and proliferating cells decreased ( Figure 5F and 5G: ie, decrease in G1 and SϩG 2 fractions in the FGD5 group compared with the sham virus-treated group). This cytostatic effect was rescued by Hey1 knockdown in FGD5-overexpressing ECs. Likewise, in an in vitro coated-bead assay, FGD5-mediated inhibition of capillary outgrowth was reversed by concomitant Hey1 silencing ( Figure 5H and 5I) .
Further studies demonstrate that FGD5-induced cell death was indeed mediated via p53 and p21 CIP1 because cotransfection of Ad-FGD5 in HUVECs with p53-or p21 CIP1 - Figure 6C and 6D ). In addition, p53 silencing reversed the growth inhibitory effects of FGD5 overexpression in the coated-bead assay ( Figure 6E  and 6F) . These data support the proapoptotic function of FGD5 in ECs during late neoangiogenesis and demonstrate involvement of the Hey1/p21 CIP1 /p53 signaling cascade in the induction of FGD5-mediated apoptosis in ECs.
FGD5 Binds and Activates cdc42 Small GTPase
To determine the direct protein target of FGD5, we assessed whether FGD5 could bind and activate small GTPase proteins like its better-known family members. FGD5 transgene expression in HUVECs did not alter total cdc42, decreased Rac1, and increased RhoA protein levels ( Figure 7A ). However, coimmunoprecipitation with an antibody against FGD5 identified cdc42 as the selective binding partner of FGD5 ( Figure 7B ), leading to specific activation of cdc42 in a GEF-activity assay ( Figure 7C-7E ). In addition, fluorescence microscopy showed colocalization of endogenous FGD5 with cdc42 at the perinuclear site in the cytoplasm of ECs ( Figure  7F and 7G) . In contrast, RhoA and Rac1 activity was significantly reduced in response to FGD5 overexpression. Because no direct binding of FGD5 to Rac1 or RhoA was observed in the coimmunoprecipitation studies, these data suggest that the inhibition of Rac1 and RhoA activity is an indirect downstream effect of FGD5.
FGD5 Level Correlates With Vascular Regression in Aging
Transgenic mice with constitutively activated cdc42 show premature aging with failing DNA repair, accelerated cell senescence, and increased p53-dependent apoptosis. 22 Similarly, cdc42 activation in cell culture was previously associated with cell senescence 23 and apoptosis, 24 whereas cdc42 deletion in hematopoietic stem cells promoted proliferation by loss of p21 CIP1 regulation during cell cycle progression. 25 To assess the role of FGD5 in aging-related vascular regres- sion, we conducted qPCR analysis of aging wild-type C57bl/6 mice ranging from early fully mature (37-41 weeks) to old (80 -92 weeks) specimens. A significant increase in GFD5 levels was observed in the oldest group of animals, which coincided with rising p21 CIP1 expression, whereas CD31 levels were diminished in the oldest group (see Figure  IV in the online-only Data Supplement).
Discussion
This study has several findings. First, FGD5 is expressed specifically in both progenitor and mature ECs, in contrast to its family members FRG, FGD1, FGD2, FGD3, FGD4, and FGD6, which show a ubiquitous expression in different cell types. In addition, this EC-specific expression is preserved throughout the evolution in different species. Second, FGD5 inhibits neovascularization, as indicated by the results obtained in vitro from tube-formation, aortic-ring, and coatedbead assays. These findings were validated in vivo by results obtained from the coated-bead plug assay and the murine retina model. Third, FGD5 binds and activates its direct downstream target, cdc42. Fourth, FGD5 inhibits neovascularization by apoptosis-induced vaso-obliteration via induction of the hey1-p53 pathway. Finally, FGD5 indeed correlates with apoptotic marker expression in Flk1 ϩ ECs during vascular remodeling in the mouse retina, whereas high levels of FGD5 expression were linked to rising p21 CIP1 mRNA levels in aging C57/bl6 wild-type mice.
Here, we define, for the first time to the best of our knowledge, the function of FGD5 as an EC-specific GEF that plays a crucial role in apoptosis-induced vascular pruning during vascular remodeling.
Vascular growth and remodeling during development and disease are tightly regulated by stimulatory and inhibitory signals that determine the complexity of the vascular tree hierarchy. Here, we describe the inhibitory role of FGD5 in vascular development, a member of the FGD family of RhoGEFs from which thus far no biological function was allocated. FGD1 was the first FGD member to be identified, and mutations in the gene were proven to be responsible for faciogenital dysplasia or Aarskog-Scott syndrome. 8 Further studies indicated that FGD1 functioned as a cdc42-specific GEF, thereby activating cdc42 signaling by exchanging bound GDP with GTP. 7 FGD2, FGD3, FGD4, and FRG were identified by genetic searches as FGD1 homologs 4 -6 and were all subsequently associated with a specific role in cdc42 activation with downstream effects on cell migration and morphology, 9 -13 whereas the function of FGD5 and FGD6 remained to be elucidated. Although the preserved cdc42 GEF activity of the different FGD members seemed to imply a redundancy in the protein family by overlapping function, the specific expression of FGD5 in ECs points toward a unique role for this particular FGD member in EC regulation. Similar to the other family members, FGD5 comprises (in order) a Dbl homology adjacent to a PH domain, followed by a FYVE-finger domain and a second C-terminal PH domain. Although the Dbl homology domain is responsible for catalytic activity, the PH domain appears to be vital for localization and full activation of this group of RhoGEFs. 6, 12, 13 Here, we show specific direct binding of FGD5 to cdc42 and demonstrate FGD5-mediated activation of cdc42. In addition, similar to recent findings that indicated colocalization of FGD1 with cdc42 in the Golgi complex in Hela cells, 26 FGD5 intracellular distribution in ECs was colocalized primarily with cdc42 in the perinuclear region. Together, these data identify cdc42 as the direct downstream target of FGD5 and assign an EC-specific RhoGEF function to this gene.
Our data also demonstrated that the effect of FGD5 could be attributed to p21 CIP1 -mediated G1/G2 cell cycle arrest, followed by p53-mediated apoptosis. Transgenic overexpression of FGD5 coincided with the upregulation of the Notch signaling pathway, including Notch1, Notch4, DLL4, and the downstream transcription factor hey1. Genetic regulation of these Notch genes could be induced after FGD5-mediated cdc42 activation via the p38 mitogen-activated protein kinase signaling pathway that regulates transcriptional activation. 27 More downstream of cdc42 toward the process of apoptosis, recent studies have indicated that hey1 triggered p53 activation through repression of HDMD2 transcription, indentifying a novel direct link between hey1 and p53. 21 Our experiments further showed that siRNA targeting of hey1 in FGD5 transgenic ECs inhibited FGD5-induced G1/G2 cell cycle arrest and cell death by reverting protein levels of p53 and p21 CIP1 back to baseline. In addition, hey1 knockdown of FGD5 transgenic HUVECs restored the sprouting capacity of these cells in the in vitro coated-bead assay, whereas siRNA targeting of p53 or p21 CIP1 in FGD5 transgenic ECs obtained similar effects on apoptosis and sprout formation. Together, our data clearly indicate FGD5-mediated cell death in ECs involves the hey1-p53-p21 CIP1 pathway.
In our studies, we demonstrated that rising endogenous FGD5 levels in the Flk1 ϩ ECs in the developing retinal vasculature were associated with the expression of the apoptosis marker cleaved caspase 3. Surprisingly, a large population of Flk1 ϩ casp3 ϩ FGD5 Ϫ cells was also observed next to the Flk1 ϩ casp3 ϩ FGD5 ϩ subpopulation, which suggests that FGD5-induced apoptosis is not the only regulatory mecha-nism of vascular pruning. Indeed, Ishida et al 3 have previously published that vascular regression in the murine retina was also regulated by infiltration of leukocytes. These cells induce apoptosis of the redundant vascular structure via a Fas ligand-mediated process. In light of these findings, our data demonstrate that FGD5 activation provides an additional mechanism that is partially responsible for the observed cell death of Flk1 ϩ ECs in the natural vascular pruning process.
Wang and coworkers 22 demonstrated that during natural aging, cdc42 activity in different organs was increased in wild-type mice. By targeting cdc42GAP (which reverses cdc42 from its active GTP-bound to its inactive GDP-bound state), they successfully created a murine strain with constitutively elevated cdc42-GTP levels. These cdc42GAP knockout animals had a prematurely aged phenotype with a failing DNA repair system and a considerably shortened average lifespan from 27 to 12 months. In addition, increased apoptosis was observed in various cell types during organ development and aging, which was dependent on p53 and p21 CIP1 activation. Cdc42GAP-null cells also showed early proliferative senescence compared with wild-type cells. 22 Cdc42 activation was previously associated with cell senescence 23 and apoptosis, 24 whereas cdc42 deletion in hemato- poietic stem cells promoted cell proliferation by deregulating p21 CIP1 levels during cell cycle progression. 25 These studies suggested a direct link between cdc42 activity and p53mediated apoptosis, which was further affirmed in our findings in which GEF activity of FGD5 elevated the level of cdc42-GTP in ECs and coincided with hey1-p53-induced cell death. FGD5-induced apoptosis could be further confirmed in vivo because high endogenous levels of FGD5 during retinal vasculature development were linked to a rise in cleaved caspase 3 levels in ECs. More important, transgenic overexpression of FGD5 in the developing murine retinal vasculature induced EC apoptosis and vascular regression, whereas FGD5 silencing promoted survival of excessive vascular structures.
Thus far, we have established an important role for FGD5 in vascular remodeling as an inducer of vascular pruning of redundant neovessels. In aging, an imbalance between cdc42 deactivation and activation could result in elevated cdc42 activity, which has severe effects on the proliferative and stress-responsive capacities of aging cells. 22 Thus, it would be interesting to study the level of FGD5 expression not only in diseases with pronounced apoptosis-induced vascular regression but also in the aging vasculature. In this study, we found a correlation between FGD5 levels and increasing levels of p21 CIP1 expression in the highly vascularized hind-limb tissue of aging wild-type mice, which coincided with a decline in CD31 EC marker expression. Currently, we are conducting further studies to elucidate the role of this EC-specific guanine exchange factor in vascular regression in the natural aging process.
Conclusions
We have identified FGD5 as a novel genetic regulator of vascular pruning of redundant neovessels by activation of targeted apoptosis. In addition, FGD5 function could prove to be a decisive factor in the survival and stability of aging vasculature.
